BSD Medical Reports First European Sale of MicroThermX Microwave Ablation System to Med-Italia Biomedica

SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.bsdmedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced the sale and shipment of the MicroThermX Microwave System to Med-Italia Biomedica (Med-Italia), one of the largest interventional radiology/oncology distributors in Italy. This is the first European sale of BSD’s MicroThermX Microwave System. BSD personnel will be attending the premiere European clinical use of the system, which will involve the treatment of a patient with a large hepatic tumor. The treatment will be carried out by a key physician in Torino, Italy. Med-Italia (http://www.meditalia.net) is a major distributor and manufacturer of products designed for the interventional radiology and oncology market in Italy. They are an exclusive distributor in Italy for a number of large medical companies, selling strategically adjacent products to the same clinicians and market that will be targeted for the MicroThermX System.

MORE ON THIS TOPIC